Clinical Trial Update: A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This document summarizes a completed Phase 2 trial evaluating the safety and effectiveness of R256918 in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• R256918

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus | Phase 2 | Status: COMPLETED